1 | 9710440 | Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway. | J Clin Invest | 1998 Aug 15 |
4 |
2 | 10669416 | Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. | Science | 2000 Feb 11 |
1 |
3 | 10669417 | Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. | Science | 2000 Feb 11 |
3 |
4 | 10847579 | Insulin and the beta3-adrenoceptor differentially regulate uncoupling protein-1 expression. | Mol Endocrinol | 2000 Jun |
1 |
5 | 11054537 | Analysis of the murine phosphoinositide 3-kinase gamma gene. | Gene | 2000 Oct 3 |
3 |
6 | 11511514 | Resistance to thromboembolism in PI3Kgamma-deficient mice. | FASEB J | 2001 Sep |
5 |
7 | 11911828 | Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. | Immunity | 2002 Mar |
3 |
8 | 12297047 | Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. | Cell | 2002 Sep 20 |
2 |
9 | 12407113 | A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. | J Biol Chem | 2003 Jan 3 |
2 |
10 | 12464394 | Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis. | Cell Signal | 2003 Feb |
1 |
11 | 12546701 | Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. | Biochem Soc Trans | 2003 Feb |
3 |
12 | 12796499 | Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. | J Biol Chem | 2003 Aug 15 |
1 |
13 | 12963636 | Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. | Circulation | 2003 Oct 28 |
2 |
14 | 14980723 | Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception. | Neuroscience | 2004 |
3 |
15 | 15231713 | Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased beta-cell mass in mice lacking the p110gamma isoform of phosphoinositide 3-kinase. | Endocrinology | 2004 Sep |
8 |
16 | 15294162 | PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. | Cell | 2004 Aug 6 |
3 |
17 | 15579443 | Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis. | Am J Pathol | 2004 Dec |
2 |
18 | 15705797 | The relative role of PLCbeta and PI3Kgamma in platelet activation. | Blood | 2005 Jul 1 |
5 |
19 | 15797027 | p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma. | Curr Biol | 2005 Mar 29 |
2 |
20 | 15824082 | Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. | J Exp Med | 2005 Apr 18 |
1 |
21 | 15860757 | Cardiac sarcoplasmic reticulum calcium release and load are enhanced by subcellular cAMP elevations in PI3Kgamma-deficient mice. | Circ Res | 2005 May 27 |
7 |
22 | 16186103 | Galpha q inhibits cardiac L-type Ca2+ channels through phosphatidylinositol 3-kinase. | J Biol Chem | 2005 Dec 2 |
1 |
23 | 16527821 | Phosphatidylinositol 3-kinase gamma signaling through protein kinase Czeta induces NADPH oxidase-mediated oxidant generation and NF-kappaB activation in endothelial cells. | J Biol Chem | 2006 Jun 9 |
1 |
24 | 16543958 | Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. | Thromb Haemost | 2006 Jan |
4 |
25 | 16789742 | Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. | J Med Chem | 2006 Jun 29 |
3 |
26 | 16856844 | Identification of the macromolecular complex responsible for PI3Kgamma-dependent regulation of cAMP levels. | Biochem Soc Trans | 2006 Aug |
4 |
27 | 16887102 | Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway. | Biochem Pharmacol | 2006 Sep 14 |
1 |
28 | 16980183 | Phosphoinositide 3-kinase gamma regulates cardiac contractility by locally controlling cyclic adenosine monophosphate levels. | Trends Cardiovasc Med | 2006 Oct |
6 |
29 | 17041586 | Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils. | Nat Cell Biol | 2006 Nov |
2 |
30 | 17284578 | Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine. | Am J Physiol Endocrinol Metab | 2007 Jun |
1 |
31 | 17322108 | Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection. | Am J Respir Crit Care Med | 2007 May 1 |
1 |
32 | 17471173 | Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of the PI3K signaling pathway. | Br J Pharmacol | 2007 Jul |
3 |
33 | 17615371 | PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes. | Circ Res | 2007 Aug 17 |
3 |
34 | 17975110 | Altered heart rate and sinoatrial node function in mice lacking the cAMP regulator phosphoinositide 3-kinase-gamma. | Circ Res | 2007 Dec 7 |
6 |
35 | 18025236 | Tissue- and stimulus-dependent role of phosphatidylinositol 3-kinase isoforms for neutrophil recruitment induced by chemoattractants in vivo. | J Immunol | 2007 Dec 1 |
3 |
36 | 18046317 | The phosphoinositide-3 kinase gamma-Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity. | Kidney Int | 2008 Feb |
2 |
37 | 18268153 | Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. | Circulation | 2008 Mar 11 |
1 |
38 | 18542100 | Role of phosphatidylinositol-3-kinase-gamma (PI3Kgamma)-mediated pathway in 17beta-estradiol-induced killing of L. mexicana in macrophages from C57BL/6 mice. | Immunol Cell Biol | 2008 Aug-Sep |
4 |
39 | 18688045 | Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning. | Circ Res | 2008 Sep 12 |
3 |
40 | 19376709 | Twice upon a time: PI3K's secret double life exposed. | Trends Biochem Sci | 2009 May |
1 |
41 | 19538942 | Phosphoinositide 3-kinase gamma inhibitor ameliorates concanavalin A-induced hepatic injury in mice. | Biochem Biophys Res Commun | 2009 Sep 4 |
1 |
42 | 19828878 | Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice. | J Pharmacol Exp Ther | 2010 Jan |
2 |
43 | 19897731 | Erythrocyte scaffolding protein p55/MPP1 functions as an essential regulator of neutrophil polarity. | Proc Natl Acad Sci U S A | 2009 Nov 24 |
2 |
44 | 19907415 | Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis. | Kidney Int | 2010 Jan |
1 |
45 | 19950590 | [Intervention effect of PI3Kgamma inhibitor AS605240 on autoimmune myocarditis in mice]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2009 Sep |
2 |
46 | 20004201 | Phosphatidylinositol 3-kinase gamma inhibition ameliorates inflammation and tumor growth in a model of colitis-associated cancer. | Gastroenterology | 2010 Apr |
1 |
47 | 20007453 | Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. | Am J Physiol Cell Physiol | 2010 Mar |
2 |
48 | 20017720 | Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease. | Recent Pat Inflamm Allergy Drug Discov | 2010 Jan |
2 |
49 | 20025958 | Involvement of phosphoinositide 3-kinase gamma in the neuro-inflammatory response and cognitive impairments induced by beta-amyloid 1-40 peptide in mice. | Brain Behav Immun | 2010 Mar |
5 |
50 | 20028656 | The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway. | J Immunol | 2010 Feb 1 |
2 |